Companies / Phio Pharmaceuticals Corp. / Activity
Activity — Phio Pharmaceuticals Corp.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Bitterman Robert J CEO | Buy | Common Stock, $.0001 par value | $9.9K | +10K +2.43% | 421,421 3.63% of shares | low |
| Dec 31, 2025 | Bitterman Robert J CEO | Buy | Common Stock, $.0001 par value | $5.2K | +5K +1.75% | 291,421 2.51% of shares | low |
| Feb 5, 2026 | Freeman Jonathan E Director | Grant | Common Stock, $.0001 par value | $0 | +17K +103.39% | 32,655 0.28% of shares | low |
| Feb 5, 2026 | Deming David H Director | Grant | Common Stock, $.0001 par value | $0 | +24K +170.00% | 37,800 0.33% of shares | low |
| Feb 5, 2026 | Lockshin Curtis Director | Grant | Common Stock, $.0001 par value | $0 | +17K +89.46% | 35,155 0.30% of shares | low |
| Feb 5, 2026 | Carson Lisa Cabott Executive | Grant | Common Stock, $.0001 par value | $0 | +47K +100.00% | 94,000 0.81% of shares | low |
| Feb 5, 2026 | Bradford Patricia a Director | Grant | Common Stock, $.0001 par value | $0 | +19K +68.14% | 45,651 0.39% of shares | low |
| Feb 5, 2026 | Bitterman Robert J CEO | Grant | Common Stock, $.0001 par value | $0 | +120K +41.18% | 411,421 3.54% of shares | low |